Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

The protocol design for the SARPAC study in #covid19 has been published, follow the link. The study initiated in March and recruitment is ongoing in five Belgian hospitals. https://t.co/koHhS5ubn2